Physician profile
Jigna Patel
NPI 1437311537
$1,556.91
in general payments reported to CMS, 2019-2025
22 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.33 · 2022: $571 · 2023: $408 · 2024: $214 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $350.26 | 2021-2023 | Reyvow, Emgality |
| Novartis Pharmaceuticals Corporation | $262.91 | 2023-2025 | |
| Abbvie INC. | $157.62 | 2022-2023 | |
| Novocure INC. | $106.09 | 2022-2024 | Optune Lua (Novottf-200t) |
| Grifols USA, LLC | $105.10 | 2025 | Gamunex-C |
| Ucb, INC. | $105.10 | 2025 | Briviact |
| Amgen INC. | $67.53 | 2021-2022 | |
| Argenx US, INC. | $62.66 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Medtronic, INC. | $57.37 | 2023 | Synchromedii, Strata |
| Impel Pharmaceuticals INC. | $44.92 | 2022-2023 | Trudhesa |
| Sk Life Science, INC. | $32.35 | 2022-2023 | |
| Pfizer INC. | $31.65 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $30.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.03 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.91 | 2023 | Gammagard |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aquestive Therapeutics, INC. | $15.64 | 2022 | |
| Neurocrine Biosciences, INC. | $15.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.00 | 2022 | |
| Hologic Sales and Service, LLC | $14.51 | 2025 | Fluent Fluid Management System |
| Eisai INC. | $14.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jigna Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.